Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
03:59:53 2026-06-04 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+20.59% | -10.38% |
| Market Cap | 297M 265M 243M 221M 419M 27.9B 429M 2.91B 1.16B 14.91B 1.12B 1.09B 46.91B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 393M 350M 322M 293M 555M 36.92B 568M 3.85B 1.54B 19.73B 1.48B 1.44B 62.09B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.8x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +20.59% | ||
| Current month | +20.59% | ||
| 1 month | +38.51% | ||
| 3 months | +11.66% | ||
| 6 months | -12.02% | ||
| Current year | -10.38% |
| 1 week | 0.16 |  | 0.21 |
| 1 month | 0.15 | | 0.21 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 0.93 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/29/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 8/9/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +20.59% | -15.95% | -77.16% | 297M | |
| +2.24% | +5.83% | +58.47% | +65.65% | 66.7B | |
| +4.66% | +5.77% | +16.93% | +82.87% | 56.88B | |
| -0.60% | +2.36% | +24.32% | +97.19% | 56.53B | |
| +2.55% | +12.69% | +30.43% | +108.45% | 46.49B | |
| +2.58% | +4.31% | +32.49% | +39.59% | 44.8B | |
| +4.09% | +4.62% | +228.06% | +845.00% | 41.59B | |
| -0.47% | +9.60% | +27.53% | +52.88% | 35.35B | |
| +3.80% | -6.42% | +98.16% | +68.09% | 33.29B | |
| +1.48% | +3.13% | -38.80% | +388.84% | 25.1B | |
| Average | +2.08% | +2.96% | +46.16% | +167.14% | 41B | |
| Weighted average by Cap. | +2.29% | +3.96% | +53.70% | +173.00% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.69M 31.9M 28.97M 54.95M 3.66B 56.24M 381M 152M 1.95B 146M 143M 6.15B |
| Net income | - | - |
| Net Debt | 96.08M 85.62M 78.72M 71.49M 136M 9.02B 139M 941M 375M 4.82B 361M 353M 15.17B | 125M 111M 102M 92.96M 176M 11.73B 180M 1.22B 488M 6.27B 469M 459M 19.73B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-09 | $0.1669 | +0.25% | 4,655,454 |
| 26-11-06 | $0.1665 | +1.02% | 4,286,379 |
| 26-11-05 | $0.1648 | -0.12% | 7,268,580 |
| 26-11-04 | $0.1650 | -2.46% | 7,737,035 |
| 26-11-03 | $0.1692 | -3.83% | 1,968,932 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1669USD
Average target price
1.000USD
Spread / Average Target
+499.16%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
